AgeneBio, Inc.
PrivateLast Round
Grant
Sep 11, 2019
Total Funding Raised
$60.95M
Company Overview
AgeneBio, Inc. is a biotechnology company that develops therapeutics designed to preserve and restore brain function for patients with neurological and psychiatric diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AgeneBio, Inc. Comparables
Compare AgeneBio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Damona Pharmaceuticals | 79% | |
| AriBio | 78% | |
| TauRx Pharmaceuticals | 77% | |
AgeneBio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 11, 2019 | ||||
| Series B | Nov 20, 2018 | ||||
| Grant | Oct 9, 2018 | ||||
| Grant | Sep 13, 2017 | ||||
| Grant | Jun 28, 2017 | ||||
Grant | Sep 15, 2015 |
AgeneBio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant, Series A |
| National Institute of Neurological Disorders and Stroke (NINDS) | Grant |
| National Institute on Aging | Grant |
| Johns Hopkins University Endowment | Grant |
| Alzheimer's Drug Discovery Foundation | Grant, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 4, 2026
Monthly visitors increased 60% MoM.
- Sep 11, 2019
$3.4M grant from Alzheimer's Drug Discovery Foundation and NIA.
AgeneBio, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about AgeneBio, Inc.'s valuation, stock price, and market status.